An associate lecturer is the first Australian to receive an international research fellowship in its 95-year history, for his project on subtyping open angle glaucoma. Read more
Only half of Australian diabetics getting recommended eye checks
As the KeepSight program hit 100,000 enrolments, a new University of Sydney study has found only half of diabetics are getting the recommended eye checks, putting them at risk of significant vision loss and blindness. Read more
Cornea transplant policy out-of-step with current evidence
A US Food and Drug Administration (FDA) policy that automatically disqualifies men who have had sex with men in the preceding five years from donating corneas is not justified by current evidence, research shows. Read more
Race to identify inherited retinal disease patients for gene therapies
Australian researchers are using genetic testing to identify as many people as possible with inherited retinal disease (IRD), in preparation for an influx of life-changing gene and stem cell therapies expected over the next decade. Read more
Aussie-engineered cornea aims to succeed where others failed
Electromaterials experts are working with Sydney ophthalmologist Professor Gerard Sutton to develop a bioengineered cornea and supporting collagen fibres to overcome two major issues with corneal transplantation. Read more
UNSW cements partnership to develop novel therapeutic contact lenses
Sydney researchers are collaborating with Uka Tarsadia University in India to investigate using contact lenses as drug delivery systems for common ocular diseases like glaucoma, dry eye and myopia. Read more
Homegrown device offers hope for complicated corneal procedure
A team of Australian researchers has received half a million dollars in medical research funding to fast-track development of a novel surgical device that addresses a common problem in delicate corneal transplant procedures. Read more
Scientists develop world’s first spherical artificial eye with 3D retina
An international research team behind the world’s first 3D artificial eye have claimed that their technology possesses greater capabilities than existing bionic eyes and even human eyes in some cases. Read more
Opthea meets US and European regulators over Phase 3 trial
A Melbourne-based drug company is one step closer to starting Phase 3 clinical trials and pre-commercial development of its novel treatment for neovascular age-related macular degeneration (nAMD). Read more
One in 10 new optometrists from NZ, study finds
The lead author of a study examining the demographics and distribution of new entrants to the Australian optometry workforce is surprised that one in 10 come from New Zealand, with almost a third of them launching their career in South Australia. Read more